Biohaven Ltd. (BHVN)
NYSE: BHVN · Real-Time Price · USD
14.39
+0.92 (6.83%)
At close: Aug 13, 2025, 4:00 PM
14.10
-0.29 (-2.02%)
Pre-market: Aug 14, 2025, 8:55 AM EDT
Biohaven Market Cap
Biohaven has a market cap or net worth of $1.52 billion as of August 14, 2025. Its market cap has decreased by -56.59% in one year.
Market Cap
1.52B
Enterprise Value
1.15B
1-Year Change
-56.59%
Ranking
Category
Stock Price
$14.39
Market Cap Chart
Since October 18, 2022, Biohaven's market cap has increased from $412.66M to $1.52B, an increase of 268.90%. That is a compound annual growth rate of 58.82%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2025 | 1.52B | -59.69% |
| Dec 31, 2024 | 3.78B | 9.99% |
| Dec 29, 2023 | 3.43B | 262.97% |
| Dec 30, 2022 | 946.07M | 129.26% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 592.95B |
| Johnson & Johnson | 420.06B |
| AbbVie | 355.91B |
| UnitedHealth Group | 246.17B |
| AstraZeneca | 240.81B |
| Novartis AG | 234.72B |
| Novo Nordisk | 227.37B |
| Abbott Laboratories | 225.22B |